[Beta receptor blocking agents in hypercirculatory syndromes and in high performance athletes].
D001775:Blood Circulation / Q000187:drug effects; D001776:Blood Circulation Time; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects*; D002306:Cardiac Volume / Q000187:drug effects; D002320:Cardiovascular Physiological Phenomena; D002319:Cardiovascular System / Q000187:drug effects; D006801:Humans; D007201:Indicator Dilution Techniques; D008297:Male; D009449:Neurocirculatory Asthenia / Q000188:drug therapy / Q000503:physiopathology*; D010101:Oxygen Consumption / Q000187:drug effects; D005082:Physical Exertion; D011433:Propranolol / Q000494:pharmacology* / Q000627:therapeutic use; D011674:Pulse / Q000187:drug effects*; D013178:Sports Medicine
D011433:Propranolol
Betarezeptorenblocker beim hyperzirkulatorischen Syndrom und beim Leistungssportler.